Guardant Health

Guardant Health Overview

Founded 2012
Founded
Status Public
Employees 622
Employees
Stock Symbol GH
Stock Symbol
Investments 3
Share Price $96.91 (As of Friday Closing)

Guardant Health General Information

Description

Guardant Health Inc is a precision oncology company. It is focused on helping conquer cancer globally through the use of proprietary blood tests, vast data sets, and advanced analytics. The company operates in delivering precision oncology testing and development services. Geographically, the company generates a majority of its revenue from the United States. its solutions include treatment selection, recurrence, and early detection.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Laboratory Services (Healthcare)
Stock Exchange
NAS
Primary Office
  • 505 Penobscot Drive
  • Redwood City, CA 94063
  • United States
+1 (855) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Guardant Health Stock Performance

(As of Tuesday closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$96.91 $95.86 $55.90 - $112.22 $9.2B 94.6M 1.26M -$0.83

Guardant Health Financials Summary

In Thousands,
USD
TTM 31-Mar-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
Enterprise Value 6,136,229 6,861,490 3,494,318
Revenue 245,230 214,375 90,639 49,842
EBITDA (78,634) (68,674) (81,104) (77,540)
Net Income (78,329) (67,851) (84,263) (83,221)
Total Assets 948,167 962,535 587,403 342,938
Total Debt 41,080 40,396 0 659
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Guardant Health Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Guardant Health‘s full profile, request access.

Request a free trial

Guardant Health Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Guardant Health‘s full profile, request access.

Request a free trial

Guardant Health Competitors (48)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
Exosomics Siena Venture Capital-Backed Siena, Italy 0000000000 0
0000000000 0000000 Corporate Backed or Acquired Cambridge, MA 000 00000 00000000000
000000000000000 Venture Capital-Backed San Diego, CA 000 000.00 0000000000 0 000.00
0000000000 Venture Capital-Backed Jerusalem, Israel 00 000.00 000000&0
00000000 Venture Capital-Backed Boulder, CO 000 00000 0000000000 0 00000

Guardant Health Executive Team (21)

Name Title Board Seat Contact Info
Helmy Eltoukhy Ph.D Chief Executive Officer & Board Member
Derek Bertocci Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
AmirAli Talasaz Ph.D Chairman & Chief Operating Officer, Operations
Michael Wiley JD Chief Legal Officer, Legal
Mark Jacobstein Chief User Engagement Officer

9 Former Executives

Guardant Health Board Members (7)

To view Guardant Health‘s full board member team, request access >>
Name Representing Role Since
Aaref Hilaly Guardant Health Board Member 000 0000
AmirAli Talasaz Ph.D Guardant Health Chairman & Chief Operating Officer, Operations 000 0000
Helmy Eltoukhy Ph.D Guardant Health Chief Executive Officer & Board Member 000 0000
Samir Kaul Khosla Ventures Board Member 000 0000
Stanley Meresman Self Board Member 000 0000

1 Former Board Member

Guardant Health Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Guardant Health‘s full profile, request access.

Request a free trial

Guardant Health Investments & Acquisitions (3)

To view Guardant Health‘s complete investment and acquisition history, request access >>
Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 21-May-2020 0000 00000 00.000 Biotechnology
0000000000 000 24-Apr-2019 000000000000000000 0000 Biotechnology 0000000 0000000 00.0
Guardant Health AMEA 01-Apr-2018 Joint Venture 0000 Biotechnology